Home › Bleeding › Washington
Bleeding clinical trials in Washington
5 studies for Bleeding are looking for participants at sites in Washington.
Cities in Washington
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Washington Institute for Coagulation, Seattle
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT05568719CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
- University of Washington Harborview Medical Center, Seattle
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Sep 29, 2026 · NCT05958342A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- University of Washingto, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- University of Washingto, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Hemophilia A Research Program
- University of Washington, Seattle
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 17, 2026 · NCT07414511From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.